Literature DB >> 7680287

Antithetical accumulation of myosin heavy chain but not alpha-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy.

C Chassagne1, C Wisnewsky, K Schwartz.   

Abstract

Myocardial response to a hemodynamic overload involves changes in the expression of isogenes encoding myosin heavy chain (MHC) and actin: beta-MHC/alpha-MHC and skeletal/cardiac alpha-actin mRNA isoform ratios are increased. It is not known whether these changes are due to increased accumulations of the two neosynthesized transcripts, beta-MHC and skeletal alpha-actin, or whether the mRNA isoforms normally present, alpha-MHC and cardiac alpha-actin, are concomitantly decreased. To answer these questions, using dot-blot hybridizations, primer extension, and exonuclease VII mapping assays, we have analyzed the content of sarcomeric MHC and actin mRNAs in the poly(A+) RNA in left ventricles of 23-24-day-old rats 18 and 24 hours after a pressure overload induced by stenosis of the thoracic aorta. The results showed a 1.9-fold increase in poly(A+) RNA after the stenosis. Skeletal/cardiac alpha-actin mRNA isoforms were already increased fivefold (from 0.19 to 0.99) at 18 hours, and this was exclusively due to a 5.5-fold increase in skeletal alpha-actin mRNA. At 24 hours, this ratio was increased ninefold (from 0.14 to 1.22), and this was due to a 4.3-fold increase in the level of skeletal alpha-actin mRNAs (p < 0.001) and a 1.9-fold decrease of cardiac alpha-actin mRNA (p < 0.001), restoring the same proportion of sarcomeric actin mRNA in sham-operated and operated rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680287     DOI: 10.1161/01.res.72.4.857

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.

Authors:  K Takeuchi; T Omura; M Yoshiyama; K Yoshida; R Otsuka; Y Shimada; K Ujino; J Yoshikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo.

Authors:  J D Molkentin; B E Markham
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

Review 3.  Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy.

Authors:  S Ghatpande; S Goswami; E Mascareno; M A Siddiqui
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

4.  Immediate postnatal rat heart development modified by abdominal aortic banding: analysis of gene expression.

Authors:  G L Engelmann; S E Campbell; K Rakusan
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

5.  Increased cardiac workload by closure of the ductus arteriosus leads to hypertrophy and apoptosis rather than to hyperplasia in the late fetal period.

Authors:  Maurice J B van den Hoff; Ronald H Lekanne Deprez; Jan M Ruijter; Piet A J de Boer; Sabina Tesink-Taekema; Anita A Buffing; Wouter H Lamers; Antoon F M Moorman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-31       Impact factor: 3.000

6.  Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium.

Authors:  K Ojamaa; J F Petrie; C Balkman; C Hong; I Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways.

Authors:  U Mende; A Kagen; A Cohen; J Aramburu; F J Schoen; E J Neer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  Tissue-restricted expression of the cardiac alpha-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two ets-binding sites.

Authors:  M Gupta; R Zak; T A Libermann; M P Gupta
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.

Authors:  Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Mol Cell Biochem       Date:  2020-06-12       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.